|Bid||73.32 x 300|
|Ask||73.33 x 900|
|Day's range||73.20 - 73.98|
|52-week range||73.20 - 94.67|
|PE ratio (TTM)||19.55|
|Earnings date||24 Apr 2018 - 30 Apr 2018|
|Forward dividend & yield||2.87 (3.65%)|
|1y target est||90.65|
Procter & Gamble (PG) continued to report sluggish margins in fiscal 3Q18. The company’s core gross margin fell 110 basis points to 49.4% in fiscal 3Q18 as lower pricing to drive volumes and increased cost pressure more than offset the benefits stemming from cost and productivity savings.
Lower pricing adversely impacted Procter & Gamble’s (PG) sales across product segments amid increased competitive activity. However, favorable currency rates and improved volumes drove top-line growth.
The Consumer Staples Select Sector SPDR ETF (XLP)—a basket of 34 companies in the sector—lost almost 3% Thursday, largely caused by the 16% drop in tobacco giant Philip Morris (PM), after its cigarette shipments fell more than expected and its heated-tobacco product—an area with high expectations for rapid growth—was experiencing headwinds in key market Japan. The company cited higher commodities and transportation costs as the cause of narrower margins, and admitted sales growth "has been challenging in a very difficult market environment." These three companies collectively comprise approximately 25% of the consumer-staples sector, which helps explain why the Consumer Staples ETF dropped 4.1% last week. It's no secret that Amazon.com (AMZN) and Walmart (WMT) have essentially made the retail space an oligopoly, says Mike O’Rourke, chief market strategist of JonesTrading.
Procter & Gamble (PG) reported net sales of $16.3 billion, a rise of 4.3% YoY (year-over-year), which exceeded analysts’ expectations. As expected, Procter & Gamble’s top line benefitted from improved volumes and favorable currency rates. Also, the improved mix contributed 1% to the net sales growth rate.
Procter & Gamble (PG) reported adjusted earnings of $1.00 per share in fiscal 3Q18, which came in ahead of analysts’ estimate of $0.98 and increased 4.2% YoY (year-over-year). Moreover, Procter & Gamble has now surpassed analysts’ earnings expectations in the past 12 quarters. However, what didn’t sit well with investors was the company’s low EPS growth rate, especially given the benefits from favorable currency rates, the low tax rate environment, and strong productivity savings.
Shares of Procter & Gamble (PG) are tumbling Friday, a day after it reported lackluster organic sales growth guidance, which overshadowed slightly better than expected third-quarter earnings. Argus’ John Staszak downgraded the shares to Hold from Buy, writing that the company’s growth has not increased to the level he expected despite divestitures. Deutsche Bank's Stephen Powers downgraded P&G to Hold from Buy and lowered his price target to $80 from $88.
Better-than-expected results and a big-ticket acquisition could not save Procter & Gamble stock. Time to stave off from staples ETFs?
Procter & Gamble (PG) reported weak sales and earnings growth in fiscal 3Q18 (period ended March 31, 2018) on April 19, 2018. The company’s stock fell 4.2% after the release and closed at $74.95. Procter & Gamble’s soft organic sales and tepid margin performance sent the stocks of other major CPG (consumer packaged goods) companies down as investors fear that price competition, business reinvestment needs, and inflation in commodities and transportation costs are likely to dent the financials of these companies.
Most of the analysts covering Colgate-Palmolive (CL) have maintained “hold” ratings on its stock as a soft sales environment, a moderating category growth rate, increased competition, and margin headwinds have kept them on the sidelines.
As for Colgate-Palmolive (CL), the company’s profit margins are likely to be adversely impacted by inflation in commodity prices, including resins and pulp. Higher logistics costs and increased advertising spending to support new product launches and drive market share are also expected to hurt its margins. Higher volumes, a focus on productivity savings, and SKU optimization are likely to support its margins.
Procter & Gamble Co., one of world’s biggest advertisers, kept its ads off YouTube for more than a year because of concerns about inappropriate content. Now it’s returning to the video site, but a lot ...
Procter & Gamble Co., the biggest advertiser in the U.S., kept its ads off YouTube for more than a year because of concerns about inappropriate content. The consumer-goods giant, which spent $2.75 billion on ads last year, according to Kantar Media, told its brands like Crest and Tide this week they can buy spots on YouTube. The Cincinnati-based company stopped spending on YouTube in March 2017 following an outcry over extremist and other disturbing videos.
Analysts expect Colgate-Palmolive (CL) to report sales of $4.0 billion in 1Q18, which represents a YoY (year-over-year) rise of 6.6%. The graph above shows that Colgate-Palmolive’s sales are showing an improving trend thanks to favorable currency rates and improvements in its volumes. Colgate-Palmolive’s top line is likely to benefit from improvements in volumes driven by new product launches in the oral and personal care segments backed by increased investments in advertising.
Stocks that moved substantially or traded heavily Thursday: Philip Morris International Inc., down $15.80 to $85.64 The tobacco company reported weak quarterly sales and said sales of its iQos device in ...
Colgate-Palmolive’s (CL) earnings have remained flat over the past two quarters as benefits from currency tailwinds, improved volumes, and cost savings have been offset by higher raw material and packaging costs, lower pricing, and advertising spending. What could drive Colgate-Palmolive’s 1Q18 EPS? Colgate-Palmolive’s bottom line is expected to benefit from an improvement in its volumes.
Colgate-Palmolive (CL) is set to announce its 1Q18 earnings on April 27, 2018. Analysts expect the company’s top line to continue to improve driven by higher volumes and increased market share. New product launches and higher advertising spending are likely to support the company’s volumes.
The Dow Jones Industrial Average on Thursday were slumping, pushing the blue-chip gauge into the red for the year and threatening a second straight decline as consumer-staples shares declined. Most recently, ...
Procter & Gamble Co will acquire the consumer health business of Merck for about 3.4 billion euros ($4.2 billion), giving it vitamin brands such as Seven Seas and greater exposure to Latin American and Asian markets. As Sonia Legg reports, the deal was announced shortly before P&G reported better than expected quarterly results.
Friday, April 20: Trump is angry at OPEC over oil prices; P&G brands return to advertising with YouTube after a year off; Lance Armstrong settles fraud lawsuit with government for $5 million. Yahoo Finance’s Dan Roberts dives in.